Multiple doses of hepatitis B recombinant vaccine for chronic hepatitis B patients with low surface antigen levels: a pilot study

[1] Lucifora J(2014)Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA Science 343 1221-1228

[2] Xia Y(2017)HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients receiving long-term nucleos(t)ide analog treatment: a systematic review and network meta-analysis PLoS One 12 e0169444-1468

[3] Reisinger F(2007)Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response Clin Gastroenterol Hepatol 5 1462-1944

[4] Zhang K(2010)Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers Hepatology 51 1933-1168

[5] Stadler D(2010)Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion PLoS Pathog 6 e1000986-4225

[6] Cheng X(2010)The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein J Immunol 185 1158-1503

[7] Xing T(2007)Characterization of hepatitis b virus (HBV)-specific T-cell dysfunction in chronic HBV infection J Virol 81 4215-778

[8] Xu H(2011)Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection Hepatology 53 1494-766

[9] Cao L(2005)Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection Hepatology 41 771-460

[10] Ye M(2010)Antigen-presenting cell function in the tolerogenic liver environment Nat Rev Immunol 10 753-787

[1] Lucifora J(2014)Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA Science 343 1221-1228

[2] Xia Y(2017)HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients receiving long-term nucleos(t)ide analog treatment: a systematic review and network meta-analysis PLoS One 12 e0169444-1468

[3] Reisinger F(2007)Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response Clin Gastroenterol Hepatol 5 1462-1944

[4] Zhang K(2010)Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers Hepatology 51 1933-1168

[5] Stadler D(2010)Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion PLoS Pathog 6 e1000986-4225

[6] Cheng X(2010)The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein J Immunol 185 1158-1503

[7] Xing T(2007)Characterization of hepatitis b virus (HBV)-specific T-cell dysfunction in chronic HBV infection J Virol 81 4215-778

[8] Xu H(2011)Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection Hepatology 53 1494-766

[9] Cao L(2005)Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection Hepatology 41 771-460

[10] Ye M(2010)Antigen-presenting cell function in the tolerogenic liver environment Nat Rev Immunol 10 753-787